218 related articles for article (PubMed ID: 28829424)
81. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.
Villanueva J; Lee S; Giannini EH; Graham TB; Passo MH; Filipovich A; Grom AA
Arthritis Res Ther; 2005; 7(1):R30-7. PubMed ID: 15642140
[TBL] [Abstract][Full Text] [Related]
82. NK Cell Isolation and Cytotoxicity by Radioactive Chromium Release Assay and DELFIA-EuTDA Cytotoxicity Assay.
Buller CW; Mathew SO
Methods Mol Biol; 2022; 2463():221-233. PubMed ID: 35344178
[TBL] [Abstract][Full Text] [Related]
83. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay.
van der Haar Àvila I; Marmol P; Kiessling R; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():167-179. PubMed ID: 30666606
[TBL] [Abstract][Full Text] [Related]
84. Assessment of natural killer cell responses to human cytomegalovirus-infected macrophages.
Wu Z; Frascaroli G; Mertens T
Methods Mol Biol; 2013; 1064():289-98. PubMed ID: 23996266
[TBL] [Abstract][Full Text] [Related]
85. Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay.
Lorenzo-Herrero S; Sordo-Bahamonde C; González S; López-Soto A
Methods Enzymol; 2020; 631():483-495. PubMed ID: 31948565
[TBL] [Abstract][Full Text] [Related]
86. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
87. Flow cytometry in detection of abnormalities of natural killer cell.
Popko K; Malinowska I; Gorska E; Stelmaszczyk-Emmel A; Demkow U
Adv Exp Med Biol; 2013; 756():303-11. PubMed ID: 22836648
[TBL] [Abstract][Full Text] [Related]
88. A simple method to measure NK cell cytotoxicity in vivo.
Saudemont A; Burke S; Colucci F
Methods Mol Biol; 2010; 612():325-34. PubMed ID: 20033651
[TBL] [Abstract][Full Text] [Related]
89. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells.
Höppner M; Luhm J; Schlenke P; Koritke P; Frohn C
J Immunol Methods; 2002 Sep; 267(2):157-63. PubMed ID: 12165437
[TBL] [Abstract][Full Text] [Related]
90. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
Du Y; Liu X; Guo SW
Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
[TBL] [Abstract][Full Text] [Related]
91. A Flow Cytometric NK Cell-Mediated Cytotoxicity Assay to Evaluate Anticancer Immune Responses In Vitro.
Lorenzo-Herrero S; Sordo-Bahamonde C; González S; López-Soto A
Methods Mol Biol; 2019; 1884():131-139. PubMed ID: 30465199
[TBL] [Abstract][Full Text] [Related]
92. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
Sung MW; Yasumura S; Johnson JT; Van Dongen GA; Whiteside TL
Int J Cancer; 1995 Jun; 61(6):864-72. PubMed ID: 7790123
[TBL] [Abstract][Full Text] [Related]
93. A flow cytometric long-term cytotoxicity assay.
Karawajew L; Jung G; Wolf H; Micheel B; Ganzel K
J Immunol Methods; 1994 Dec; 177(1-2):119-30. PubMed ID: 7822818
[TBL] [Abstract][Full Text] [Related]
94. Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry.
Schönberg K; Hejazi M; Uhrberg M
Methods Mol Biol; 2012; 903():381-92. PubMed ID: 22782833
[TBL] [Abstract][Full Text] [Related]
95. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
96. A novel CD2 staining-based flow cytometric assay for assessment of natural killer cell cytotoxicity.
Zhang D; Teng R; Lv N; Lei L; Wang Y; Williamson RA; Chen P; Gao P; O'Dwyer M; Li A; Hu J
J Clin Lab Anal; 2020 Dec; 34(12):e23519. PubMed ID: 32808354
[TBL] [Abstract][Full Text] [Related]
97. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
98. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
Sibbitt WL; Mathews PM; Bankhurst AD
Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
[TBL] [Abstract][Full Text] [Related]
99. Identification of Primary Natural Killer Cell Modulators by Chemical Library Screening with a Luciferase-Based Functional Assay.
Hayek S; Bekaddour N; Besson L; Alves de Sousa R; Pietrancosta N; Viel S; Smith N; Jacob Y; Nisole S; Mandal R; Wishart DS; Walzer T; Herbeuval JP; Vidalain PO
SLAS Discov; 2019 Jan; 24(1):25-37. PubMed ID: 30184441
[TBL] [Abstract][Full Text] [Related]
100. Flow cytometry-based
Wong P; Wagner JA; Berrien-Elliott MM; Schappe T; Fehniger TA
STAR Protoc; 2021 Mar; 2(1):100262. PubMed ID: 33490978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
